Table 3. Gender differences in the therapy for CHD by country.
All 3 Countries | Germany | UK | US | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||||||
Male | Female | p | Male | Female | p | Male | Female | p | Male | Female | p | |
CHD appropriate prescription (%) | 50* | 39* | .015* | 22 | 12 | .139 | 58* | 39* | .044* | 70 | 64 | .458 |
Referral to a cardiologist or specialist facility (%) | 25* | 15* | .011* | 27* | 11* | .037* | 39* | 23* | .037* | 9 | 11 | .764 |
Referral to other medical professional (%) | 33* | 25* | .044* | 61* | 42* | .027* | 31 | 30 | .853 | 8 | 3 | .185 |
Days to next appointment (mean) | 9.6 | 10.5 | .167 | 4.7 | 6.8 | .080 | 12.3 | 14.0 | .218 | 11.8 | 10.7 | .510 |
Abbreviation: CHD, coronary heart disease.
p < .05.